Haleon/HLN

$8.45

-1.28%
-
1D1W1MYTD1YMAX

About Haleon

Haleon plc is a consumer healthcare company. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

Ticker

HLN

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Brian Mcnamara

Employees

21,000

Headquarters

Brentford, United Kingdom

Haleon Metrics

BasicAdvanced
$38.49B
Market cap
24.82
P/E ratio
$0.34
EPS
-
Beta
-
Dividend rate
1.78%
Dividend yield

What the Analysts think about Haleon

Analyst Ratings

Majority rating from 2 analysts.
Buy

Price Targets

Average projection from 2 analysts.
15.62% upside
High $10.13
Low $9.42
$8.45
Current price
$9.77
Average price target

Haleon Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
13.04% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
£2.8B
1.67%
Net income
£365M
22.48%
Profit margin
13.04%
20.52%

Haleon Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 36.29%
QuarterlyAnnual
Q4 23
Q1 24
Actual
£0.07
-
Expected
£0.10
£0.10
Surprise
-36.29%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Haleon stock

Buy or sell Haleon stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing